MEDICAL PRODUCT AND PHARMACEUTICAL COMPOSITION COMPRISING AS ACTIVE INGREDIENTS A THROMBOLYTIC AGENT AND LEVOSIMENDAN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND THE USE OF SAME IN THE MANUFACTURE OF MEDICAMENT FOR REDUCING MORTALITY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
A combination therapy for the treatment of acute myocardial infarction comprises administering a combination of a thrombolytic agent and levosimendan or a pharmaceutically acceptable salt thereof to a patient. The combination synergistically reduces mortality of patients with acute myocardial infarction.
